TECH 📈 Bio-Techne - Overview

Bio-Techne Corp is a leading developer, manufacturer, and supplier of life science reagents, instruments, and services, catering to the global research, diagnostics, and bioprocessing markets. The company's operations are divided into two primary segments: Protein Sciences and Diagnostics and Genomics. Through these segments, Bio-Techne Corp provides a comprehensive range of products and services that facilitate advancements in life science research, diagnostics, and cell and gene therapy.

The Protein Sciences segment is focused on developing and manufacturing biological reagents, including cytokines, growth factors, antibodies, and small molecules, which are used in various aspects of life science research and diagnostics. Additionally, this segment offers proteomic analytical tools, such as automated western blot and multiplexed ELISA workflow solutions, which enable researchers to quantify proteins in various biological fluids. These tools are designed to streamline protein analysis and provide accurate results, thereby accelerating the discovery and development of new therapies.

The Diagnostics and Genomics segment is dedicated to developing and manufacturing diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market. This segment also offers exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. Furthermore, the company provides products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications.

Bio-Techne Corp has established strategic partnerships to accelerate breakthroughs in various fields, including neurodegenerative disease research and treatment. For instance, the company has partnered with ALZpath, Inc. to advance research and treatment of Alzheimer's disease. With a history dating back to 1976, Bio-Techne Corp has evolved significantly, changing its name from Techne Corporation to Bio-Techne Corporation in 2014. The company is headquartered in Minneapolis, Minnesota, and its common stock is listed on the NASDAQ stock exchange under the ticker symbol TECH.

As a leading player in the life sciences tools and services industry, Bio-Techne Corp is committed to providing innovative products and services that enable researchers, clinicians, and scientists to advance their work and make new discoveries. With a strong focus on research and development, the company continues to expand its product portfolio and capabilities, addressing the evolving needs of the life science community. Through its website, https://www.bio-techne.com, Bio-Techne Corp provides access to its products, services, and resources, facilitating collaboration and innovation in the life sciences industry.